Table 2 Clinical information of patients with clear cell renal cell carcinoma in the TCGA
Characteristics | Low expression of SERPINE1 | High expression of SERPINE1 | p-value |
|---|---|---|---|
n | 270 | 271 | Â |
Age, n (%) | Â | Â | 0.111605111 |
 <  = 60 | 125 (23.1%) | 144 (26.6%) |  |
 > 60 | 145 (26.8%) | 127 (23.5%) |  |
Gender, n (%) | Â | Â | 8.16029E-06 |
 Female | 118 (21.8%) | 69 (12.8%) |  |
 Male | 152 (28.1%) | 202 (37.3%) |  |
Pathologic T stage, n (%) | Â | Â | 0.009964032 |
 T1&T2 | 189 (34.9%) | 161 (29.8%) |  |
 T3&T4 | 81 (15%) | 110 (20.3%) |  |
Pathologic N stage, n (%) | Â | Â | 0.018326564 |
 N0 | 134 (51.9%) | 108 (41.9%) |  |
 N1 | 4 (1.6%) | 12 (4.7%) |  |
Pathologic M stage, n (%) | Â | Â | 0.24744979 |
 M0 | 215 (42.3%) | 214 (42.1%) |  |
 M1 | 34 (6.7%) | 45 (8.9%) |  |
Pathologic stage, n (%) | Â | Â | 0.015713843 |
 Stage I&Stage II | 179 (33.3%) | 153 (28.4%) |  |
 Stage III&Stage IV | 89 (16.5%) | 117 (21.7%) |  |
Histologic grade, n (%) | Â | Â | 0.008439461 |
 G1&G2 | 139 (26.1%) | 111 (20.8%) |  |
 G3&G4 | 125 (23.5%) | 158 (29.6%) |  |